Kiri Industries Limited share price

NSE: KIRIINDUS · ISIN INE415I01015

Key numbers

Market cap
₹ 3,633 Cr
Current price
₹ 557.50
52-week high / low
₹ 779 / 334
Stock P/E
0.6
Book value
₹ 1,052.0
Dividend yield
0.00%
ROCE
110.1%
ROE
115.0%
Debt to equity
0.01
Sales growth (3 yrs)
-3.6%
Profit growth (3 yrs)
273.7%
1-year return
-5.1%

About Kiri Industries Limited

Kiri Industries Limited manufactures and sells dyes, dye intermediates, and basic chemicals in India and internationally. It provides reactive dyes, acid dyes, direct dyes, and disperse dyes; and basic chemicals comprising sulphuric acid, chloro sulhponic acid, oleum, spent sulphuric acid, and thionyl chloride. The company also offers dye intermediates, such as sulpho J.acid, sulpho tobias acid, sulpho gama acid, and para nitro toluene ortho sulfonic acid, vinyl sulphone, as well as H-Acid, naphthalene, and aniline based intermediates. It sells its products to chemical, dyes, dyes intermediates, pharma, paper and textile industries through dealers and distributors. The company was formerly known as Kiri Dyes and Chemicals Limited and changed its name to Kiri Industries Limited in March 2011. Kiri Industries Limited was incorporated in 1998 and is based in Ahmedabad, India.

Quarterly results

Consolidated figures in ₹ crores

Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales202213174251312
Operating profit-16-14-49-14216
Net profit10205,022515290
EPS (₹)1.913.27834.3984.1344.89

Concall summary (2026-08-18)

AI summary of the earnings call transcript · tone: Positive · source document

Guidance & outlook

  • During the quarter, our standalone material margin improved to 31.9%, compared with 23.5% in Q1 FY26 and 20.4% in Q4 FY26.
  • On a consolidated basis, revenue from operations from Quarter 1 FY 2027 stood at INR 312 crores, registering a growth of 55% year-on-year.

Growth & demand

  • Now, coming to the financial performance for the quarter: On a standalone basis, revenue from operations for Quarter 1 FY '27 stood at INR 295 crore, registering a growth of 63% year-on-year.
  • The growth was led principally by improved price realizations across the product portfolio rather than by volume.

Margins & costs

  • However, improved average selling realizations across our product portfolio, together with effective pass-through of higher raw material costs, supported our material margins and helped sustain profitability.
  • Standalone EBITDA stood at INR 17 crore with an EBITDA margin of 5.86%.

Capex & expansion

  • The downstream of copper facilities are planned to be commissioned in phases, with the copper tube targeted by Quarter 1 FY '28, followed by copper rod plant FY '28 and copper refinery in Quarter 3 FY '29.
  • As one of the largest global producers of H-acid, we believe our existing capacity provides headroom to participate in rising demand without significant additional capital expenditures.

Balance sheet & cash

  • Finance costs reduced sharply following the repayment of borrowings at Claronex Holdings Pte.
  • Ltd., leaving the group substantially free of external debt.

Peers in Specialty Chemicals

Data for information only, not investment advice. Prices end of day.